Breast implants have been marketed for decades as a way to enhance confidence and body image. Yet, what many women are not told is that breast implants can interfere with one of the most important aspects of their long-term health: breast cancer screening. Not only can implants obscure mammogram images and make it harder to detect abnormalities early, but in some cases, they may also be linked to a rare but serious type of cancer known as breast implant–associated anaplastic large cell lymphoma (BIA-ALCL).
At Executive Plastic Surgery in Bloomfield Township, Dr. Shaher Khan, a double board-certified surgeon and nationally recognized specialist in Breast Implant Illness, has dedicated his career to educating women on these risks. In this article, you will learn how implants can affect breast cancer screening and how you can protect your long-term health.
How breast implants affect cancer detection
Breast cancer is most effectively treated when it is caught early. Mammograms, ultrasound, and MRI imaging are the primary tools used for detection. However, if you have implants, they can block part of the breast tissue during imaging. Silicone or saline implants may obscure certain areas, reducing the visibility of suspicious lumps or calcifications.
While radiologists can use specialized views, called implant-displaced techniques, these methods still don’t guarantee a complete look at all breast tissue. This means your mammogram results may appear normal even if small tumors are present. The false sense of security can delay diagnosis, ultimately impacting your treatment options and survival outcomes.
The risk of implant-associated cancers
Beyond the problem of obscured screening, implants themselves may increase your cancer risk in specific ways. The most well-documented concern is breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare cancer of the immune system. It develops in the scar tissue and fluid surrounding the implant, not in the breast tissue itself.
BIA-ALCL has been reported more frequently with textured implants, though smooth implants are not risk-free. Some of the most common symptoms of BIA-ALCL include swelling, persistent pain, or fluid buildup years after the original surgery. Left undiagnosed, this type of cancer can progress, but when detected early, the outcomes are far better.
What the FDA and medical societies say
The FDA has issued multiple warnings about breast implants. In 2021, the FDA required manufacturers to include a black box warning (its strongest caution) on all implant packaging. Patients must also be given a checklist outlining risks, including BIA-ALCL, systemic symptoms (called Breast Implant Illness), and the fact that implants are not lifetime devices.
Despite these warnings, implants continue to be on the market. Many medical organizations now emphasize the importance of ongoing screening and also acknowledge the limitations of mammograms in women with implants. This means the responsibility falls on you, the patient, to stay vigilant, ask the right questions, and pursue additional imaging when needed.
